Balance Sheet Abbott India Limited

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:48 10/04/2026 pm IST			5-day change	1st Jan Change
25,770.05 ^INR	-0.11%		-1.92%	-11.35%

27/02	Abbott India partners with Novo Nordisk India to launch Extensior	RE
27/02	Abbott Partners with Novo Nordisk India to Launch Extensior, Broadening Access to Semaglutide for Advanced Diabetes Management	CI

d1824c3dfef45c325.EEWHub3rtipmLCosdb1MPbFPtDXIQWg2keYIgt4zVKc.RDTL1O-p9FgnRVxALfMOU8Q2_F68Ez1j4LV_06tDY-ZnK-3376eFTDZbZw

Published financial data: ABBOTT INDIA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	4.31TCr	4.92TCr	5.35TCr	5.85TCr	6.41TCr
Total Revenues	4.31TCr	4.92TCr	5.35TCr	5.85TCr	6.41TCr
Cost of Goods Sold, Total	2.4TCr	2.67TCr	2.99TCr	3.23TCr	3.51TCr
Gross Profit	1.91TCr	2.25TCr	2.36TCr	2.62TCr	2.9TCr
Selling General & Admin Expenses, Total	612.61Cr	735.55Cr	685.45Cr	691.02Cr	690.37Cr
Provision for Bad Debts	-	-	-	-	2.47Cr
Depreciation & Amortization - (IS)	58Cr	66Cr	70Cr	71Cr	72Cr
Other Operating Expenses	371.67Cr	423.9Cr	467Cr	469.57Cr	508.26Cr
Other Operating Expenses, Total	1.04TCr	1.23TCr	1.22TCr	1.23TCr	1.27TCr
Operating Income	867.34Cr	1.03TCr	1.14TCr	1.38TCr	1.63TCr
Interest Expense, Total	-15Cr	-15Cr	-12Cr	-8.88Cr	-7.1Cr
Interest And Investment Income	80Cr	76Cr	144.06Cr	224Cr	258.72Cr
Net Interest Expenses	64Cr	61Cr	131.82Cr	215.12Cr	251.62Cr
Currency Exchange Gains (Loss)	-3.76Cr	-4.16Cr	-4.31Cr	-2.53Cr	-2.66Cr
Other Non Operating Income (Expenses)	-1.87Cr	-2.53Cr	-1.34Cr	88L	-2.82Cr
EBT, Excl. Unusual Items	926.17Cr	1.08TCr	1.27TCr	1.6TCr	1.87TCr
Gain (Loss) On Sale Of Assets	-25L	-	-26L	16L	-65L
Insurance Settlements	-	-	-	-	67L
Other Unusual Items	3L	-	7.68Cr	20Cr	15Cr
EBT, Incl. Unusual Items	925.95Cr	1.08TCr	1.27TCr	1.62TCr	1.89TCr
Income Tax Expense	235.26Cr	281.03Cr	324.41Cr	416.53Cr	472.51Cr
Earnings From Continuing Operations	690.69Cr	798.7Cr	949.41Cr	1.2TCr	1.41TCr
Net Income to Company	690.69Cr	798.7Cr	949.41Cr	1.2TCr	1.41TCr
Net Income - (IS)	690.69Cr	798.7Cr	949.41Cr	1.2TCr	1.41TCr
Net Income to Common Incl Extra Items	690.69Cr	798.7Cr	949.41Cr	1.2TCr	1.41TCr
Net Income to Common Excl. Extra Items	690.69Cr	798.7Cr	949.41Cr	1.2TCr	1.41TCr
Per Share Items
Net EPS - Basic	325.04	375.87	446.8	565.3	665.64
Basic EPS - Continuing Operations	325.04	375.87	446.8	565.3	665.64
Basic Weighted Average Shares Outstanding	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
Net EPS - Diluted	325.04	375.87	446.8	565.3	665.64
Diluted EPS - Continuing Operations	325.04	375.87	446.8	565.3	665.64
Diluted Weighted Average Shares Outstanding	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
Normalized Basic EPS	272.41	317.58	372.48	469.99	550.68
Normalized Diluted EPS	272.41	317.58	372.48	469.99	550.68
Dividend Per Share	120	145	180	410	475
Payout Ratio	32.92	31.93	32.45	31.84	61.59
Supplemental Items
EBITDA	884.42Cr	1.05TCr	1.17TCr	1.41TCr	1.66TCr
EBITA	867.51Cr	1.03TCr	1.14TCr	1.39TCr	1.63TCr
EBIT	867.34Cr	1.03TCr	1.14TCr	1.38TCr	1.63TCr
EBITDAR	884.67Cr	1.05TCr	1.17TCr	1.41TCr	1.66TCr
Total Revenues (As Reported)	4.39TCr	5TCr	5.5TCr	6.1TCr	6.68TCr
Effective Tax Rate - (Ratio)	25.41	26.03	25.47	25.75	25.04
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	239.05Cr	281.16Cr	325.6Cr	415.43Cr	477.99Cr
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-3.79Cr	-13L	-1.19Cr	1.07Cr	2.72Cr
Normalized Net Income	578.86Cr	674.83Cr	791.5Cr	998.71Cr	1.17TCr
Interest on Long-Term Debt	15Cr	15Cr	12Cr	8.67Cr	7.04Cr
Non-Cash Pension Expense	85L	41L	30L	-1.35Cr	61L
Supplemental Operating Expense Items
Advertising Expense	119.71Cr	155.77Cr	121.6Cr	114.14Cr	102.56Cr
Selling and Marketing Expenses	119.71Cr	155.77Cr	121.6Cr	114.14Cr	102.56Cr
Research And Development Expense From Footnotes	84L	81L	79L	96L	1.04Cr
Net Rental Expense, Total	25L	32L	26L	30L	27L
Imputed Operating Lease Interest Expense	18.64L	25.95L	19.22L	21.7L	10.96L
Imputed Operating Lease Depreciation	6L	6L	7L	8L	16.04L
Maintenance & Repair Expenses, Total	9.36Cr	11Cr	11Cr	12Cr	13Cr
Stock-Based Comp., SG&A Exp. (Total)	9.75Cr	13Cr	12Cr	14Cr	12Cr
Total Stock-Based Compensation	9.75Cr	13Cr	12Cr	14Cr	12Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	218.27Cr	132.71Cr	239.67Cr	291.74Cr	560.59Cr
Short Term Investments	2.18TCr	2.6TCr	1.68TCr	1.83TCr	2.55TCr
Total Cash And Short Term Investments	2.4TCr	2.74TCr	1.92TCr	2.12TCr	3.11TCr
Accounts Receivable, Total	250.21Cr	288.16Cr	316.95Cr	319.11Cr	380.23Cr
Other Receivables	116.64Cr	100.45Cr	94Cr	124.69Cr	320.96Cr
Notes Receivable	4.95Cr	-	-	-	-
Total Receivables	371.8Cr	388.61Cr	411.39Cr	443.8Cr	701.19Cr
Inventory	717.59Cr	687.82Cr	648.85Cr	619.58Cr	882.04Cr
Prepaid Expenses	5.78Cr	6.97Cr	6.73Cr	9.01Cr	8.79Cr
Restricted Cash	6.44Cr	9.3Cr	11Cr	13Cr	18Cr
Other Current Assets, Total	16Cr	25Cr	24Cr	42Cr	42Cr
Total Current Assets	3.52TCr	3.85TCr	3.03TCr	3.25TCr	4.77TCr
Gross Property Plant And Equipment	334.01Cr	366.83Cr	354.62Cr	374.64Cr	511.34Cr
Accumulated Depreciation	-84Cr	-103.8Cr	-121.57Cr	-146.25Cr	-163.74Cr
Net Property Plant And Equipment	250.27Cr	263.03Cr	233.05Cr	228.39Cr	347.6Cr
Long-term Investments	-	-	1.14TCr	1.51TCr	672Cr
Other Intangibles, Total	1.17Cr	8.63Cr	7.52Cr	6.66Cr	6.46Cr
Loans Receivable Long-Term	14Cr	-	-	-	-
Deferred Tax Assets Long-Term	18Cr	17Cr	17Cr	16Cr	15Cr
Other Long-Term Assets, Total	38Cr	82Cr	135.9Cr	190.75Cr	111.18Cr
Total Assets	3.84TCr	4.22TCr	4.56TCr	5.19TCr	5.92TCr
Liabilities
Accounts Payable, Total	762.67Cr	889.45Cr	891.99Cr	1TCr	1.06TCr
Accrued Expenses, Total	98Cr	133.8Cr	120.83Cr	125.71Cr	137.21Cr
Current Portion of Leases	35Cr	43Cr	46Cr	46Cr	39Cr
Current Income Taxes Payable	15Cr	12Cr	11Cr	11Cr	20Cr
Unearned Revenue Current, Total	6.04Cr	4.07Cr	4.71Cr	7.4Cr	4.38Cr
Other Current Liabilities	113.44Cr	121.06Cr	132.27Cr	148.99Cr	149.17Cr
Total Current Liabilities	1.03TCr	1.2TCr	1.21TCr	1.34TCr	1.41TCr
Long-Term Leases	117.68Cr	108.74Cr	67Cr	37Cr	157.75Cr
Pension & Other Post Retirement Benefits	5.06Cr	3.24Cr	2.63Cr	3.19Cr	3.33Cr
Other Non Current Liabilities	85Cr	89Cr	91Cr	111.93Cr	115.89Cr
Total Liabilities	1.24TCr	1.4TCr	1.37TCr	1.49TCr	1.68TCr
Common Stock, Total	21Cr	21Cr	21Cr	21Cr	21Cr
Retained Earnings	2.54TCr	2.75TCr	3.12TCr	3.63TCr	4.18TCr
Comprehensive Income and Other	43Cr	45Cr	47Cr	45Cr	28Cr
Total Common Equity	2.6TCr	2.82TCr	3.19TCr	3.7TCr	4.23TCr
Total Equity	2.6TCr	2.82TCr	3.19TCr	3.7TCr	4.23TCr
Total Liabilities And Equity	3.84TCr	4.22TCr	4.56TCr	5.19TCr	5.92TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
ECS Total Common Shares Outstanding	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
Book Value / Share	1.22T	1.33T	1.5T	1.74T	1.99T
Tangible Book Value	2.6TCr	2.81TCr	3.18TCr	3.69TCr	4.23TCr
Tangible Book Value Per Share	1.22T	1.32T	1.5T	1.74T	1.99T
Total Debt	152.58Cr	151.69Cr	113.17Cr	83Cr	196.67Cr
Net Debt	-2.25TCr	-2.58TCr	-1.81TCr	-2.03TCr	-2.92TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.42Cr	6L	42L	4.47Cr	18Cr
Debt Equivalent Oper. Leases	2Cr	2.56Cr	2.08Cr	2.4Cr	2.16Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	164.14Cr	112.09Cr	139.21Cr	117.67Cr	199.45Cr
Inventories - Work In Process, Total	18Cr	9.34Cr	15Cr	18Cr	20Cr
Inventories - Finished Goods, Total	535.6Cr	566.39Cr	494.36Cr	484.15Cr	662.16Cr
Inventories - Others	-	-	-	-	-
Land - (BS)	38L	-	-	-	-
Buildings, Total	52Cr	54Cr	55Cr	61Cr	31Cr
Machinery, Total	133.75Cr	171.85Cr	195.61Cr	231.86Cr	265.32Cr
Full Time Employees	3.58T	3.6T	3.7T	3.81T	3.66T
Accumulated Allowance for Doubtful Accounts (Supple)	12Cr	13Cr	12Cr	14Cr	13Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	690.69Cr	798.7Cr	949.41Cr	1.2TCr	1.41TCr
Depreciation & Amortization - CF	56Cr	65Cr	69Cr	70Cr	70Cr
Amortization of Goodwill and Intangible Assets - (CF)	17L	81L	91L	85L	1.74Cr
Depreciation & Amortization, Total	57Cr	66Cr	70Cr	71Cr	72Cr
Amortization of Deferred Charges, Total - (CF)	49L	38L	37L	39L	24L
(Gain) Loss From Sale Of Asset	25L	-	26L	-16L	65L
Stock-Based Compensation (CF)	9.75Cr	13Cr	12Cr	14Cr	12Cr
Provision and Write-off of Bad Debts	2.8Cr	1.22Cr	-9L	1.39Cr	1.98Cr
Other Operating Activities, Total	-45Cr	-60Cr	-161.51Cr	-204.26Cr	-225.92Cr
Change In Accounts Receivable	65Cr	-39Cr	-29Cr	-1.68Cr	-63Cr
Change In Inventories	-190.42Cr	30Cr	39Cr	29Cr	-262.47Cr
Change In Accounts Payable	108.94Cr	115.12Cr	-1.41Cr	96Cr	41Cr
Change in Other Net Operating Assets	28Cr	23Cr	14Cr	5.85Cr	22Cr
Cash from Operations	726.74Cr	947.66Cr	893.39Cr	1.21TCr	1.01TCr
Capital Expenditure	-23Cr	-44Cr	-34Cr	-48Cr	-53Cr
Sale of Property, Plant, and Equipment	13L	23L	48L	20L	52L
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-135.12Cr	-420.99Cr	-216.32Cr	-511.53Cr	108.83Cr
Other Investing Activities, Total	86Cr	69Cr	102.24Cr	143.63Cr	125.43Cr
Cash from Investing	-72Cr	-395.84Cr	-147.71Cr	-416.03Cr	182.18Cr
Long-Term Debt Repaid, Total	-50Cr	-52Cr	-54Cr	-54Cr	-47Cr
Total Debt Repaid	-50Cr	-52Cr	-54Cr	-54Cr	-47Cr
Common Dividends Paid	-227.37Cr	-255Cr	-308.11Cr	-382.49Cr	-871.22Cr
Common & Preferred Stock Dividends Paid	-227.37Cr	-255Cr	-308.11Cr	-382.49Cr	-871.22Cr
Special Dividend Paid	-303.86Cr	-329.36Cr	-276.25Cr	-308.11Cr	-
Other Financing Activities, Total	-51L	-70L	-49L	-20L	-7.1Cr
Cash from Financing	-581.79Cr	-637.38Cr	-638.72Cr	-744.71Cr	-925.17Cr
Net Change in Cash	73Cr	-86Cr	106.96Cr	52Cr	268.85Cr
Supplemental Items
Cash Interest Paid	51L	70L	49L	20L	7.1Cr
Cash Income Tax Paid (Refund)	235.46Cr	288.99Cr	340.86Cr	404.47Cr	447.06Cr
Levered Free Cash Flow	611.31Cr	802.76Cr	768.32Cr	1.01TCr	591.33Cr
Unlevered Free Cash Flow	620.85Cr	812.4Cr	775.97Cr	1.01TCr	595.77Cr
Change In Net Working Capital	-35Cr	-136.33Cr	-15Cr	-110.77Cr	452.06Cr
Net Debt Issued / Repaid	-50Cr	-52Cr	-54Cr	-54Cr	-47Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	14.68	15.9	16.23	17.75	18.29
Return on Total Capital	20.22	22.39	22.72	24.43	24.75
Return On Equity %	27.44	29.46	31.6	34.88	35.66
Return on Common Equity	27.44	29.46	31.6	34.88	35.66
Margin Analysis
Gross Profit Margin %	44.31	45.77	44.17	44.73	45.23
SG&A Margin	14.21	14.95	12.82	11.81	10.77
EBITDA Margin %	20.52	21.3	21.79	24.13	25.83
EBITA Margin %	20.13	20.87	21.33	23.68	25.4
EBIT Margin %	20.12	20.85	21.32	23.67	25.37
Income From Continuing Operations Margin %	16.03	16.24	17.75	20.54	22.07
Net Income Margin %	16.03	16.24	17.75	20.54	22.07
Net Avail. For Common Margin %	16.03	16.24	17.75	20.54	22.07
Normalized Net Income Margin	13.43	13.72	14.8	17.08	18.26
Levered Free Cash Flow Margin	14.18	16.32	14.36	17.22	9.23
Unlevered Free Cash Flow Margin	14.4	16.51	14.51	17.32	9.3
Asset Turnover
Asset Turnover	1.17	1.22	1.22	1.2	1.15
Fixed Assets Turnover	16.55	19.17	21.56	25.35	22.25
Receivables Turnover (Average Receivables)	15.17	18.27	17.68	18.34	18.33
Inventory Turnover (Average Inventory)	3.86	3.8	4.47	5.1	4.68
Short Term Liquidity
Current Ratio	3.41	3.2	2.51	2.42	3.39
Quick Ratio	2.68	2.6	1.94	1.91	2.71
Operating Cash Flow to Current Liabilities	0.7	0.79	0.74	0.9	0.72
Days Sales Outstanding (Average Receivables)	24.06	19.97	20.65	19.96	19.91
Days Outstanding Inventory (Average Inventory)	94.64	96.14	81.69	71.8	78.07
Average Days Payable Outstanding	100.06	114.29	110.32	108.24	99.68
Cash Conversion Cycle (Average Days)	18.64	1.82	-7.98	-16.47	-1.69
Long Term Solvency
Total Debt/Equity	5.86	5.38	3.55	2.25	4.65
Total Debt / Total Capital	5.54	5.1	3.43	2.2	4.44
LT Debt/Equity	4.52	3.86	2.12	0.99	3.73
Long-Term Debt / Total Capital	4.27	3.66	2.04	0.97	3.56
Total Liabilities / Total Assets	32.24	33.25	30.01	28.78	28.46
EBIT / Interest Expense	56.84	66.52	93.16	155.91	229.03
EBITDA / Interest Expense	60.54	70.78	98.84	163.88	239.11
(EBITDA - Capex) / Interest Expense	59.02	67.93	96.06	158.44	231.7
Total Debt / EBITDA	0.17	0.14	0.09	0.06	0.12
Net Debt / EBITDA	-2.43	-2.37	-1.5	-1.4	-1.72
Total Debt / (EBITDA - Capex)	0.17	0.14	0.1	0.06	0.12
Net Debt / (EBITDA - Capex)	-2.5	-2.47	-1.54	-1.45	-1.77
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.3	14.14	8.86	9.35	9.58
Gross Profit, 1 Yr. Growth %	8.02	17.89	5.22	10.73	10.81
EBITDA, 1 Yr. Growth %	22.54	18.45	11.89	21.17	17.27
EBITA, 1 Yr. Growth %	22.94	18.34	11.81	21.45	17.51
EBIT, 1 Yr. Growth %	22.94	18.27	11.81	21.47	17.45
Earnings From Cont. Operations, 1 Yr. Growth %	16.49	15.64	18.87	26.52	17.75
Net Income, 1 Yr. Growth %	16.49	15.64	18.87	26.52	17.75
Normalized Net Income, 1 Yr. Growth %	15.31	16.58	17.8	26.23	17.37
Diluted EPS Before Extra, 1 Yr. Growth %	16.49	15.64	18.87	26.52	17.75
Accounts Receivable, 1 Yr. Growth %	-21.3	15.17	9.99	0.1	19.15
Inventory, 1 Yr. Growth %	36.12	-4.15	-5.67	-4.51	42.36
Net Property, Plant and Equip., 1 Yr. Growth %	-7.5	5.1	-11.4	-2	52.2
Total Assets, 1 Yr. Growth %	8.28	9.99	7.85	14	13.94
Tangible Book Value, 1 Yr. Growth %	7	8.08	13.16	16.07	14.48
Common Equity, 1 Yr. Growth %	7.01	8.36	13.08	16.01	14.44
Cash From Operations, 1 Yr. Growth %	16.07	30.4	-5.73	35.75	-16.57
Capital Expenditures, 1 Yr. Growth %	48.09	89.06	-22.6	41.69	8.84
Levered Free Cash Flow, 1 Yr. Growth %	9.94	25.32	-3.84	31.17	-41.3
Unlevered Free Cash Flow, 1 Yr. Growth %	10.89	24.96	-4.04	30.6	-41.19
Dividend Per Share, 1 Yr. Growth %	12.15	20.83	24.14	127.78	15.85
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.24	9.63	11.4	9.11	9.46
Gross Profit, 2 Yr. CAGR %	9.9	12.84	11.23	7.94	10.77
EBITDA, 2 Yr. CAGR %	20.59	20.48	14.8	16.41	19.2
EBITA, 2 Yr. CAGR %	21.01	20.62	14.69	16.5	19.46
EBIT, 2 Yr. CAGR %	21.02	20.58	14.66	16.51	19.45
Earnings From Cont. Operations, 2 Yr. CAGR %	23.84	16.06	17.24	22.64	22.06
Net Income, 2 Yr. CAGR %	23.84	16.06	17.24	22.64	22.06
Normalized Net Income, 2 Yr. CAGR %	15.92	15.94	16.93	21.92	21.61
Diluted EPS Before Extra, 2 Yr. CAGR %	23.84	16.06	17.24	22.64	22.06
Accounts Receivable, 2 Yr. CAGR %	-4.81	-4.79	12.55	5.23	9.21
Inventory, 2 Yr. CAGR %	8.75	14.23	-4.91	-5.09	16.59
Net Property, Plant and Equip., 2 Yr. CAGR %	55.25	-1.4	-3.5	-6.82	22.13
Total Assets, 2 Yr. CAGR %	14.27	9.13	8.91	10.88	13.97
Tangible Book Value, 2 Yr. CAGR %	13.85	7.54	10.59	14.6	15.27
Common Equity, 2 Yr. CAGR %	13.82	7.68	10.7	14.53	15.22
Cash From Operations, 2 Yr. CAGR %	20.67	23.03	10.87	13.13	6.42
Capital Expenditures, 2 Yr. CAGR %	37.59	67.33	20.97	4.72	24.18
Levered Free Cash Flow, 2 Yr. CAGR %	-8.6	20.16	9.52	12.28	-12.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	-7.9	20.46	9.25	11.92	-12.36
Dividend Per Share, 2 Yr. CAGR %	54.92	16.41	22.47	68.15	62.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.33	10.17	9.33	10.71	9.26
Gross Profit, 3 Yr. CAGR %	11.27	12.5	10.15	11.06	8.89
EBITDA, 3 Yr. CAGR %	18.7	19.87	17.32	16.87	16.7
EBITA, 3 Yr. CAGR %	19.04	20.11	17.38	16.88	16.84
EBIT, 3 Yr. CAGR %	19.08	20.09	17.36	16.87	16.83
Earnings From Cont. Operations, 3 Yr. CAGR %	19.85	21.05	16.99	20.26	20.99
Net Income, 3 Yr. CAGR %	19.85	21.05	16.99	20.26	20.99
Normalized Net Income, 3 Yr. CAGR %	14.21	16.14	16.39	19.94	20.31
Diluted EPS Before Extra, 3 Yr. CAGR %	19.85	21.05	16.99	20.26	20.99
Accounts Receivable, 3 Yr. CAGR %	-1.7	1.43	-0.1	8.45	9.68
Inventory, 3 Yr. CAGR %	7.03	4.27	7.17	-4.78	8.64
Net Property, Plant and Equip., 3 Yr. CAGR %	45.8	36.32	-4.85	-3	9.74
Total Assets, 3 Yr. CAGR %	16.7	12.83	8.7	10.58	11.89
Tangible Book Value, 3 Yr. CAGR %	15.46	11.89	9.38	12.39	14.56
Common Equity, 3 Yr. CAGR %	15.41	11.97	9.45	12.44	14.5
Cash From Operations, 3 Yr. CAGR %	68.21	23.83	12.58	18.61	2.21
Capital Expenditures, 3 Yr. CAGR %	11.66	52.96	29.41	27.51	6.08
Levered Free Cash Flow, 3 Yr. CAGR %	197.3	3.14	11.38	16.29	-9.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	204.01	3.54	11.49	15.93	-9.68
Dividend Per Share, 3 Yr. CAGR %	33.89	42.6	18.93	50.61	48.52
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.51	11.13	10.15	9.72	9.38
Gross Profit, 5 Yr. CAGR %	11.37	13.74	11.25	10.6	10.4
EBITDA, 5 Yr. CAGR %	19.24	21.17	17.13	18.34	18.06
EBITA, 5 Yr. CAGR %	19.66	21.61	17.28	18.52	18.2
EBIT, 5 Yr. CAGR %	19.66	21.59	17.29	18.51	18.18
Earnings From Cont. Operations, 5 Yr. CAGR %	22.03	23.62	18.8	21.68	18.99
Net Income, 5 Yr. CAGR %	22.03	23.62	18.8	21.68	18.99
Normalized Net Income, 5 Yr. CAGR %	18.39	19.85	15.29	18.32	18.44
Diluted EPS Before Extra, 5 Yr. CAGR %	22.03	23.62	18.8	21.68	18.99
Accounts Receivable, 5 Yr. CAGR %	11.08	10.34	3.77	2.94	3.64
Inventory, 5 Yr. CAGR %	14.16	6.56	2.08	0.42	10.84
Net Property, Plant and Equip., 5 Yr. CAGR %	18.35	18.45	23.61	17.07	5.14
Total Assets, 5 Yr. CAGR %	18.89	15.38	13.52	12.05	10.78
Tangible Book Value, 5 Yr. CAGR %	16.89	15.23	13.48	12.97	11.7
Common Equity, 5 Yr. CAGR %	16.83	15.25	13.5	12.99	11.73
Cash From Operations, 5 Yr. CAGR %	23.92	25.27	42.38	19.43	10.08
Capital Expenditures, 5 Yr. CAGR %	0.51	16.36	15.29	31.45	27.29
Levered Free Cash Flow, 5 Yr. CAGR %	29.07	21.89	101.27	6.6	1.24
Unlevered Free Cash Flow, 5 Yr. CAGR %	29.39	22.18	103.75	6.72	1.25
Dividend Per Share, 5 Yr. CAGR %	27.94	29.38	29.2	52.32	34.73